1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. KAMADA LTD
8.23 0.03 (0.37%)
2,647.9
XNAS Volume

XNAS 28 Apr, 2026 9:48 AM (EDT)

Watchlist

Portfolio

Alert



Insider Trading disclosures for Kamada Ltd

The latest disclosure was made by Chaime Orlev in Kamada Ltd where a trade of 22,500 Employee Stock Option (right to buy) done was reported to US exchanges on April 7, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Chaime Orlev Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2026 22,500 22,500 - - Employee Stock Option (right to buy)
Chaime Orlev Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Apr 2026 22,500 22,500 - - Employee Stock Option (right to buy)
Chaime Orlev Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Apr 2026 22,500 22,500 - - Employee Stock Option (right to buy)
Chaime Orlev Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2026 22,500 22,500 - - Employee Stock Option (right to buy)
Chaime Orlev Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Apr 2026 22,500 22,500 - - Employee Stock Option (right to buy)
Chaime Orlev Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2026 22,500 22,500 - - Employee Stock Option (right to buy)
Chaime Orlev Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Apr 2026 22,500 22,500 - - Employee Stock Option (right to buy)
Chaime Orlev Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2026 22,500 22,500 - - Employee Stock Option (right to buy)
Chaime Orlev Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Apr 2026 22,500 22,500 - - Employee Stock Option (right to buy)
Chaime Orlev Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2026 22,500 22,500 - - Employee Stock Option (right to buy)
Chaime Orlev Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Apr 2026 22,500 22,500 - - Employee Stock Option (right to buy)
Chaime Orlev Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2026 22,500 22,500 - - Employee Stock Option (right to buy)
Chaime Orlev Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Apr 2026 22,500 22,500 - - Employee Stock Option (right to buy)
Chaime Orlev Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2026 22,500 22,500 - - Employee Stock Option (right to buy)
Chaime Orlev Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Apr 2026 22,500 22,500 - - Employee Stock Option (right to buy)
Chaime Orlev Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2026 22,500 22,500 - - Employee Stock Option (right to buy)
Chaime Orlev Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Apr 2026 22,500 22,500 - - Employee Stock Option (right to buy)
Leon Y. Recanati Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Apr 2026 6,625 6,625 - - Employee Stock Option (right to buy)
Leon Y. Recanati Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Apr 2026 6,625 6,625 - - Employee Stock Option (right to buy)
Leon Y. Recanati Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2026 6,625 6,625 - - Employee Stock Option (right to buy)
Leon Y. Recanati Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Apr 2026 6,625 6,625 - - Employee Stock Option (right to buy)
Leon Y. Recanati Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2026 6,625 6,625 - - Employee Stock Option (right to buy)
Leon Y. Recanati Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Apr 2026 6,625 6,625 - - Employee Stock Option (right to buy)
Leon Y. Recanati Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2026 7,500 7,500 - - Employee Stock Option (right to buy)
Leon Y. Recanati Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Apr 2026 7,500 7,500 - - Employee Stock Option (right to buy)
Leon Y. Recanati Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2026 6,625 6,625 - - Employee Stock Option (right to buy)
Leon Y. Recanati Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2026 6,625 6,625 - - Employee Stock Option (right to buy)
Leon Y. Recanati Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2026 7,500 7,500 - - Employee Stock Option (right to buy)
Leon Y. Recanati Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Apr 2026 7,500 7,500 - - Employee Stock Option (right to buy)
Leon Y. Recanati Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2026 7,500 7,500 - - Employee Stock Option (right to buy)
Leon Y. Recanati Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Apr 2026 7,500 7,500 - - Employee Stock Option (right to buy)
Leon Y. Recanati Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2026 7,500 7,500 - - Employee Stock Option (right to buy)
Leon Y. Recanati Director Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Apr 2026 7,500 7,500 - - Employee Stock Option (right to buy)
Chaime Orlev Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2026 22,500 22,500 - - Employee Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures